These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


741 related items for PubMed ID: 12619038

  • 1. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F, Djakiew D.
    Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
    [Abstract] [Full Text] [Related]

  • 2. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB, Rutka JT, Hubbard SL, Mondal S, Hamel PA.
    Oncogene; 1998 Aug 20; 17(7):867-76. PubMed ID: 9780003
    [Abstract] [Full Text] [Related]

  • 3. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

  • 4. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K, Vlach J, Hennecke S, Amati B.
    EMBO J; 1997 Sep 01; 16(17):5322-33. PubMed ID: 9311992
    [Abstract] [Full Text] [Related]

  • 5. Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosourea-induced mammary carcinomas in rats.
    Jiang W, Zhu Z, Thompson HJ.
    Cancer Res; 2003 Mar 15; 63(6):1228-34. PubMed ID: 12649181
    [Abstract] [Full Text] [Related]

  • 6. The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells.
    Khwaja F, Tabassum A, Allen J, Djakiew D.
    Biochem Biophys Res Commun; 2006 Mar 24; 341(4):1184-92. PubMed ID: 16460673
    [Abstract] [Full Text] [Related]

  • 7. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L, Allen KE, La Thangue NB.
    Nat Cell Biol; 2000 Apr 24; 2(4):232-9. PubMed ID: 10783242
    [Abstract] [Full Text] [Related]

  • 8. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
    Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM.
    Exp Cell Res; 1997 Aug 01; 234(2):293-9. PubMed ID: 9260897
    [Abstract] [Full Text] [Related]

  • 9. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
    Howard CM, Claudio PP, De Luca A, Stiegler P, Jori FP, Safdar NM, Caputi M, Khalili K, Giordano A.
    Cancer Res; 2000 May 15; 60(10):2737-44. PubMed ID: 10825149
    [Abstract] [Full Text] [Related]

  • 10. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.
    Sueoka N, Lee HY, Walsh GL, Hong WK, Kurie JM.
    Cancer Res; 1999 Aug 01; 59(15):3838-44. PubMed ID: 10447003
    [Abstract] [Full Text] [Related]

  • 11. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
    Liu Y, Lu C, Shen Q, Munoz-Medellin D, Kim H, Brown PH.
    Oncogene; 2004 Oct 28; 23(50):8238-46. PubMed ID: 15378019
    [Abstract] [Full Text] [Related]

  • 12. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest.
    Dhillon NK, Mudryj M.
    Oncogene; 2002 Jul 11; 21(30):4626-34. PubMed ID: 12096339
    [Abstract] [Full Text] [Related]

  • 13. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
    Strobeck MW, Fribourg AF, Puga A, Knudsen ES.
    Oncogene; 2000 Apr 06; 19(15):1857-67. PubMed ID: 10773875
    [Abstract] [Full Text] [Related]

  • 14. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine.
    Gollapudi L, Neet KE.
    J Neurosci Res; 1997 Aug 15; 49(4):461-74. PubMed ID: 9285522
    [Abstract] [Full Text] [Related]

  • 15. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML, LaCava M, Gimenez-Conti IB, Johnson DG, Conti CJ.
    Oncogene; 1998 Oct 29; 17(17):2251-8. PubMed ID: 9811455
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of cell cycle arrest by methylseleninic acid.
    Zhu Z, Jiang W, Ganther HE, Thompson HJ.
    Cancer Res; 2002 Jan 01; 62(1):156-64. PubMed ID: 11782373
    [Abstract] [Full Text] [Related]

  • 17. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
    Baptist M, Lamy F, Gannon J, Hunt T, Dumont JE, Roger PP.
    J Cell Physiol; 1996 Feb 01; 166(2):256-73. PubMed ID: 8591985
    [Abstract] [Full Text] [Related]

  • 18. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K, Kumagai T, Shimizu T, Takeda K.
    Int J Mol Med; 2005 Feb 01; 15(2):253-8. PubMed ID: 15647840
    [Abstract] [Full Text] [Related]

  • 19. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.
    Woo CW, Lucarelli E, Thiele CJ.
    Oncogene; 2004 Feb 26; 23(8):1522-30. PubMed ID: 14691455
    [Abstract] [Full Text] [Related]

  • 20. Tumor suppressor proteins as regulators of cell differentiation.
    Li ZR, Hromchak R, Mudipalli A, Bloch A.
    Cancer Res; 1998 Oct 01; 58(19):4282-7. PubMed ID: 9766653
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.